Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells.

Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R, Salazar EP.

Clin Exp Metastasis. 2010 Oct;27(7):505-15. doi: 10.1007/s10585-010-9340-1. Epub 2010 Jul 9.

PMID:
20617371
[PubMed - indexed for MEDLINE]
2.

Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway.

Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Martinez-Orozco R, Salazar EP.

Int J Biochem Cell Biol. 2010 Feb;42(2):306-17. doi: 10.1016/j.biocel.2009.11.010. Epub 2009 Nov 18.

PMID:
19931412
[PubMed - indexed for MEDLINE]
3.

Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells.

Soto-Guzman A, Robledo T, Lopez-Perez M, Salazar EP.

Mol Cell Endocrinol. 2008 Nov 6;294(1-2):81-91. doi: 10.1016/j.mce.2008.08.003. Epub 2008 Aug 15.

PMID:
18775472
[PubMed - indexed for MEDLINE]
4.

Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.

Das R, Mahabeleshwar GH, Kundu GC.

J Biol Chem. 2004 Mar 19;279(12):11051-64. Epub 2004 Jan 2.

PMID:
14704150
[PubMed - indexed for MEDLINE]
Free Article
5.

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.

PMID:
19796390
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.

Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.

Carcinogenesis. 2009 Jul;30(7):1225-33. doi: 10.1093/carcin/bgp111. Epub 2009 May 6.

PMID:
19420016
[PubMed - indexed for MEDLINE]
Free Article
8.

Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells.

Castro-Sanchez L, Soto-Guzman A, Guaderrama-Diaz M, Cortes-Reynosa P, Salazar EP.

Clin Exp Metastasis. 2011 Jun;28(5):463-77. doi: 10.1007/s10585-011-9385-9. Epub 2011 Apr 2.

PMID:
21461859
[PubMed - indexed for MEDLINE]
9.

Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.

Simeone AM, Nieves-Alicea R, McMurtry VC, Colella S, Krahe R, Tari AM.

Int J Oncol. 2007 Apr;30(4):785-92.

PMID:
17332916
[PubMed - indexed for MEDLINE]
10.

Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.

Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV, Salazar EP.

Matrix Biol. 2008 Apr;27(3):220-31. Epub 2007 Nov 12.

PMID:
18061419
[PubMed - indexed for MEDLINE]
11.

Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.

Kondapaka SB, Fridman R, Reddy KB.

Int J Cancer. 1997 Mar 17;70(6):722-6.

PMID:
9096655
[PubMed - indexed for MEDLINE]
12.

Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells.

Ehrenfeld P, Conejeros I, Pavicic MF, Matus CE, Gonzalez CB, Quest AF, Bhoola KD, Poblete MT, Burgos RA, Figueroa CD.

Cancer Lett. 2011 Feb 1;301(1):106-18. doi: 10.1016/j.canlet.2010.09.020. Epub 2010 Dec 13.

PMID:
21147512
[PubMed - indexed for MEDLINE]
13.

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.

Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS.

Mol Cancer Res. 2006 Jul;4(7):437-47.

PMID:
16849519
[PubMed - indexed for MEDLINE]
Free Article
14.

Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells.

Navarro-Tito N, Robledo T, Salazar EP.

Exp Cell Res. 2008 Nov 1;314(18):3340-55. doi: 10.1016/j.yexcr.2008.08.018. Epub 2008 Sep 9.

PMID:
18804105
[PubMed - indexed for MEDLINE]
15.

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines.

Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, Kilpatrick L, Yilmazer A, Paish EC, Ellis IO, Patel PM, Jackson AM.

Breast Cancer Res. 2008;10(6):R95. doi: 10.1186/bcr2195. Epub 2008 Nov 17.

PMID:
19014637
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.

Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Dec 3;279(49):51630-46. Epub 2004 Sep 7.

PMID:
15355971
[PubMed - indexed for MEDLINE]
Free Article
17.

Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.

Canning MT, Postovit LM, Clarke SH, Graham CH.

Exp Cell Res. 2001 Jul 1;267(1):88-94.

PMID:
11412041
[PubMed - indexed for MEDLINE]
18.
19.

Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.

Chia JS, Du JL, Hsu WB, Sun A, Chiang CP, Wang WB.

BMC Cancer. 2010 Apr 30;10:175. doi: 10.1186/1471-2407-10-175.

PMID:
20429953
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A.

Martinez-Orozco R, Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Perez Salazar E.

Eur J Cell Biol. 2010 Jun;89(6):476-88. doi: 10.1016/j.ejcb.2009.12.005. Epub 2010 Mar 6.

PMID:
20207443
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk